We are live on
!
Find out more
RWC
Rare Wolf Capital Portfolio holdings
AUM
$156M
This Fund
S&P 500
This Quarter
Est. Return
-6.54%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$154M
AUM Growth
-$5.71M
(-3.6%)
Cap. Flow
+$5.41M
Cap. Flow
% of AUM
3.51%
Top 10 Holdings %
Top 10 Hldgs %
43.66%
Holding
137
New
14
Increased
46
Reduced
28
Closed
10
Avg Time Held
0.9
quarters
Top 10 Avg Time Held
0.9
quarters
Top 20 Avg Time Held
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.49M |
| 2 |
ServiceNow
NOW
|
+$1.6M |
| 3 |
Adobe
ADBE
|
+$1.37M |
| 4 |
Hercules Capital
HTGC
|
+$1.24M |
| 5 |
WisdomTree Floating Rate Treasury Fund
USFR
|
+$954K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$1.91M |
| 2 |
Charter Communications
CHTR
|
+$1.37M |
| 3 |
Dow Inc
DOW
|
+$1.26M |
| 4 |
Pfizer
PFE
|
+$1.13M |
| 5 |
Tesla
TSLA
|
+$1.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.76% |
| 2 | Miscellaneous | 20.13% |
| 3 | Communication Services | 17.8% |
| 4 | Consumer Discretionary | 9.72% |
| 5 | Healthcare | 7.03% |
Similar funds
ACL
SC
BF
JAA
FLP
RB
CP
CWM
Rare Wolf Capital's Q1 2026 Portfolio in Review
As of Q1 2026, Rare Wolf Capital held 137 positions worth $154M, down 3.6% from $160M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Rare Wolf Capital deployed $5.41M of net new capital in Q1 2026, opening 14 new positions and adding to 46 existing holdings. Its largest new stake was Intuit: 1,365 shares worth $590K.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Miscellaneous and Communication Services.
On the sell side, the largest reduction was Pfizer, an estimated $1.13M trimmed.
- Rare Wolf Capital's largest Q1 2026 buy was Intuit: 1,365 shares worth $590K.
- Rare Wolf Capital added most to Microsoft in Q1 2026, an estimated $2.49M increase.
- Rare Wolf Capital's biggest Q1 2026 reduction was Pfizer, cutting an estimated $1.13M.
- Rare Wolf Capital fully exited Novo Nordisk in Q1 2026, selling an estimated $1.91M.
- Rare Wolf Capital's ten largest holdings make up 44% of its $154M portfolio in Q1 2026.
- Rare Wolf Capital opened 14 new positions and closed 10 in Q1 2026.
- Rare Wolf Capital's portfolio value fell 3.6% quarter-over-quarter to $154M.
Based on Rare Wolf Capital's 13F filing for Q1 2026, filed 14 May 2026.